DK434586A - Amidinderivater ii - Google Patents

Amidinderivater ii Download PDF

Info

Publication number
DK434586A
DK434586A DK434586A DK434586A DK434586A DK 434586 A DK434586 A DK 434586A DK 434586 A DK434586 A DK 434586A DK 434586 A DK434586 A DK 434586A DK 434586 A DK434586 A DK 434586A
Authority
DK
Denmark
Prior art keywords
amidine derivatives
amidine
derivatives
Prior art date
Application number
DK434586A
Other languages
English (en)
Other versions
DK169920B1 (da
DK434586D0 (da
Inventor
Peter Bod
Kalman Harsanye
Eva Csongor
Erik Bogsch
Eva Fekecs
Ferenc Trischler
Gyoergy Domany
Istvan Szabadkai
Bela Hegedues
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10963968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK434586(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of DK434586D0 publication Critical patent/DK434586D0/da
Publication of DK434586A publication Critical patent/DK434586A/da
Application granted granted Critical
Publication of DK169920B1 publication Critical patent/DK169920B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK434586A 1985-09-11 1986-09-10 Fremgangsmåde til fremstilling af N-sulfamyl-3-(2-guanidinothiazol-4-ylmethylthio)propionamidin DK169920B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU342485 1985-09-11
HU853424A HU194845B (en) 1985-09-11 1985-09-11 Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin

Publications (3)

Publication Number Publication Date
DK434586D0 DK434586D0 (da) 1986-09-10
DK434586A true DK434586A (da) 1987-03-12
DK169920B1 DK169920B1 (da) 1995-04-03

Family

ID=10963968

Family Applications (1)

Application Number Title Priority Date Filing Date
DK434586A DK169920B1 (da) 1985-09-11 1986-09-10 Fremgangsmåde til fremstilling af N-sulfamyl-3-(2-guanidinothiazol-4-ylmethylthio)propionamidin

Country Status (22)

Country Link
US (1) US4835281A (da)
JP (1) JPH0645609B2 (da)
KR (1) KR910000237B1 (da)
CN (1) CN1013674B (da)
AR (1) AR240319A1 (da)
AT (1) AT386824B (da)
AU (1) AU587279B2 (da)
BE (1) BE905409A (da)
CA (1) CA1263120A (da)
DD (1) DD249479A5 (da)
DK (1) DK169920B1 (da)
ES (1) ES2001677A6 (da)
FI (1) FI86423C (da)
GB (1) GB2180237B (da)
GE (1) GEP19960471B (da)
GR (1) GR862308B (da)
HU (1) HU194845B (da)
NL (1) NL8602225A (da)
NO (1) NO163010C (da)
PT (1) PT83348B (da)
SE (1) SE8603797L (da)
SU (1) SU1450743A3 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU194845B (en) * 1985-09-11 1988-03-28 Richter Gedeon Vegyeszet Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin
HU196775B (en) * 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
NO882037L (no) * 1987-06-22 1988-12-23 Marga Para La Investigacion Sa Famotidin, polymerte former og fremstilling derav.
US5856500A (en) * 1997-03-11 1999-01-05 Albemarle Corporation Synthesis of thiazole derivatives
US5731442A (en) * 1997-03-11 1998-03-24 Albemarle Corporation Synthesis of thiazole derivatives
JP2002529503A (ja) * 1998-11-17 2002-09-10 ニトロメッド,インク. ニトロソ化及びニトロシル化h2リセプターアンタゴニスト化合物及び組成物並びにその利用方法
WO2009058997A2 (en) * 2007-11-01 2009-05-07 Biocept Inc. Non-invasive isolation of fetal nucleic acid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法
US4808589A (en) * 1982-02-20 1989-02-28 Smith Kline & French Laboratories Limited Pyrimidone derivatives
US4496737A (en) * 1982-09-27 1985-01-29 Merck & Co., Inc. Process for preparing sulfamylamidine antisecretory agents
ES526303A0 (es) * 1983-10-07 1985-04-01 Inke Sa Procedimiento para la obtencion de (-1amino-3-(((2-((diaminometileno) amino)-4-tiazolil)metil)tio)propilideno)sulfamida
ES8506665A1 (es) * 1984-05-07 1985-08-01 Inke Sa Procedimiento para la obtencion de la 1-amino-3-2-diamino-metilen-amino-4-tiazolil-metil-tio-propiliden-sulfamida.
ES536322A0 (es) * 1984-09-27 1985-08-01 Bioiberica Procedimiento para la obtencion del n-aminosolfenil-3-(((2-guanidin-4-tiazonil)metil)tio) propionamidina
ES536803A0 (es) * 1984-10-17 1985-08-01 Inke Sa Procedimiento para la obtencion de la (1-amino-3(((2-((diamino-metilen) amino)-4-tiazolil)metil)tio)propiliden)sulfamida
HU193608B (en) * 1985-09-11 1987-11-30 Richter Gedeon Vegyeszet Process for production of new dervatives of n-sulphanol-propion-amidine
HU194845B (en) * 1985-09-11 1988-03-28 Richter Gedeon Vegyeszet Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin
JP3751649B2 (ja) * 1994-12-01 2006-03-01 関西ペイント株式会社 自動車外板塗膜の一時保護方法

Also Published As

Publication number Publication date
US4835281A (en) 1989-05-30
NO863616D0 (no) 1986-09-10
DD249479A5 (de) 1987-09-09
CA1263120A (en) 1989-11-21
BE905409A (fr) 1986-12-31
NO163010C (no) 1990-03-21
AU587279B2 (en) 1989-08-10
AR240319A1 (es) 1990-03-30
GEP19960471B (en) 1996-05-13
ATA243486A (de) 1988-03-15
GB8621742D0 (en) 1986-10-15
ES2001677A6 (es) 1988-06-01
FI863657A (fi) 1987-03-12
HU194845B (en) 1988-03-28
AT386824B (de) 1988-10-25
FI86423C (fi) 1992-08-25
SE8603797D0 (sv) 1986-09-10
CN1013674B (zh) 1991-08-28
JPS6296481A (ja) 1987-05-02
CN86105909A (zh) 1987-05-13
SE8603797L (sv) 1987-03-12
FI863657A0 (fi) 1986-09-10
NO863616L (no) 1987-03-12
DK169920B1 (da) 1995-04-03
JPH0645609B2 (ja) 1994-06-15
GB2180237B (en) 1989-09-06
GR862308B (en) 1987-01-02
PT83348B (pt) 1988-07-29
SU1450743A3 (ru) 1989-01-07
PT83348A (pt) 1986-10-01
DK434586D0 (da) 1986-09-10
NO163010B (no) 1989-12-11
KR910000237B1 (ko) 1991-01-23
KR870003078A (ko) 1987-04-15
GB2180237A (en) 1987-03-25
FI86423B (fi) 1992-05-15
HUT42766A (en) 1987-08-28
NL8602225A (nl) 1987-04-01
AU6256986A (en) 1987-03-12

Similar Documents

Publication Publication Date Title
DK394586D0 (da) Fungicidt aktive propenoatderivater
IT1197151B (it) Sottomaterasso
DK272686D0 (da) Benzazepinderivater
DK109186A (da) Dihydropyridazinonderivater
DE3650527D1 (de) Imidazolderivate
DK595686D0 (da) Benzazepinderivater
NO168368C (no) Smoereoljeblanding
DK434586D0 (da) Amidinderivater ii
DK491786D0 (da) Dichloranilinderivater
BR8606663A (pt) Derivados de triazolil-quinolina
DK448386A (da) Imidazolderivater
DK566386A (da) Vandtaarn
DK556386A (da) Quinilinderivater
DK303886A (da) Secocanthinderivater
DK434486A (da) Amidinderivater i
DE3662889D1 (de) Tetrahydrofurancarboxylic-acid derivatives
KR880700821A (ko) 데--데옥시테이코플라닌 유도체
DK109086A (da) 2-aminopyrimidinonderivater
IT8621669A1 (it) Guidastoppino
DE3662890D1 (de) Furobenzisoxazole derivatives
KR870002798U (ko) 장구
DK111685A (da) Letvaeskespaerre
BR6501997U (pt) Barateira
KR860012066U (ko) 관 접 속 구
SE8504114D0 (sv) Forbindning

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired